Cargando…

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis

BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Jéssica A., Rodrigues, Lucas A., Columbus, Daniel A., Aguirre, Juan C. P., Harding, John C. S., Cantarelli, Vinícius S., Costa, Matheus de O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383374/
https://www.ncbi.nlm.nih.gov/pubmed/34429170
http://dx.doi.org/10.1186/s40813-021-00228-9
_version_ 1783741725149233152
author Barbosa, Jéssica A.
Rodrigues, Lucas A.
Columbus, Daniel A.
Aguirre, Juan C. P.
Harding, John C. S.
Cantarelli, Vinícius S.
Costa, Matheus de O.
author_facet Barbosa, Jéssica A.
Rodrigues, Lucas A.
Columbus, Daniel A.
Aguirre, Juan C. P.
Harding, John C. S.
Cantarelli, Vinícius S.
Costa, Matheus de O.
author_sort Barbosa, Jéssica A.
collection PubMed
description BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea. This study investigated the usefulness of fecal calprotectin as a biomarker of intestinal inflammation in Brachyspira hyodysenteriae and Salmonella Typhimurium infected pigs. RESULTS: Fecal samples from pigs with colitis (n = 18) were collected from animals experimentally inoculated with B. hyodysenteriae (n = 8) or from sham-inoculated controls (n = 3). Fecal samples from pigs with enteritis (n = 14) were collected from animals inoculated with Salmonella enterica serovar Typhimurium (n = 8) or from sham-inoculated controls (n = 4). For both groups, fecal samples were scored as: 0 = normal; 1 = soft, wet cement; 2 = watery feces; 3 = mucoid diarrhea; and 4 = bloody diarrhea. Fecal calprotectin levels were assayed using a sandwich ELISA, a turbidimetric immunoassay and a point-of-care dipstick test. Fecal calprotectin levels were greater in colitis samples scoring 4 versus ≤ 4 using ELISA, and in feces scoring 3 and 4 versus ≤ 1 using immunoturbidimetry (P < 0.05). No differences were found in calprotectin concentration among fecal scores for enteritis samples, regardless of the assay used. All samples were found below detection limits using the dipstick method. CONCLUSIONS: Fecal calprotectin levels are increased following the development of colitis, but do not significantly change due to enteritis. While practical, the use of commercially available human kits present sensitivity limitations. Further studies are needed to validate the field application of calprotectin as a marker of intestinal inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00228-9.
format Online
Article
Text
id pubmed-8383374
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83833742021-08-25 Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis Barbosa, Jéssica A. Rodrigues, Lucas A. Columbus, Daniel A. Aguirre, Juan C. P. Harding, John C. S. Cantarelli, Vinícius S. Costa, Matheus de O. Porcine Health Manag Research BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea. This study investigated the usefulness of fecal calprotectin as a biomarker of intestinal inflammation in Brachyspira hyodysenteriae and Salmonella Typhimurium infected pigs. RESULTS: Fecal samples from pigs with colitis (n = 18) were collected from animals experimentally inoculated with B. hyodysenteriae (n = 8) or from sham-inoculated controls (n = 3). Fecal samples from pigs with enteritis (n = 14) were collected from animals inoculated with Salmonella enterica serovar Typhimurium (n = 8) or from sham-inoculated controls (n = 4). For both groups, fecal samples were scored as: 0 = normal; 1 = soft, wet cement; 2 = watery feces; 3 = mucoid diarrhea; and 4 = bloody diarrhea. Fecal calprotectin levels were assayed using a sandwich ELISA, a turbidimetric immunoassay and a point-of-care dipstick test. Fecal calprotectin levels were greater in colitis samples scoring 4 versus ≤ 4 using ELISA, and in feces scoring 3 and 4 versus ≤ 1 using immunoturbidimetry (P < 0.05). No differences were found in calprotectin concentration among fecal scores for enteritis samples, regardless of the assay used. All samples were found below detection limits using the dipstick method. CONCLUSIONS: Fecal calprotectin levels are increased following the development of colitis, but do not significantly change due to enteritis. While practical, the use of commercially available human kits present sensitivity limitations. Further studies are needed to validate the field application of calprotectin as a marker of intestinal inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00228-9. BioMed Central 2021-08-24 /pmc/articles/PMC8383374/ /pubmed/34429170 http://dx.doi.org/10.1186/s40813-021-00228-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Barbosa, Jéssica A.
Rodrigues, Lucas A.
Columbus, Daniel A.
Aguirre, Juan C. P.
Harding, John C. S.
Cantarelli, Vinícius S.
Costa, Matheus de O.
Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title_full Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title_fullStr Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title_full_unstemmed Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title_short Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
title_sort experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383374/
https://www.ncbi.nlm.nih.gov/pubmed/34429170
http://dx.doi.org/10.1186/s40813-021-00228-9
work_keys_str_mv AT barbosajessicaa experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT rodrigueslucasa experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT columbusdaniela experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT aguirrejuancp experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT hardingjohncs experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT cantarelliviniciuss experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis
AT costamatheusdeo experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis